Golden State Equity Partners’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,700
Closed -$27.2K 532
2024
Q3
$27.2K Buy
+1,700
New +$27.2K 0.01% 472
2022
Q1
$143K Buy
15,970
+2,100
+15% +$18.8K 0.07% 185
2021
Q4
$156K Buy
+13,870
New +$156K 0.08% 166